Transcriptomics Technologies Market: Market Overview
Transcriptomics is the study of transcriptomes and is a useful source for analyzing gene expressions and the functioning pattern of each gene in an organism.
According to the latest research by Fact.MR, the Transcriptomics Technologies market is set to witness a high growth rate during 2021-2031. The transcriptomics technologies market is set to achieve this steady growth during the forecast period due to factors such as the rise in applications of RNA sequencing applied in transcriptomic research. Growing funding by the government in genomic research also adds to the growth of the transcriptomics technologies market. Furthermore, the applications of transcriptomics in the discipline of toxicogenomics will fuel the future demand.
Demand drivers for the Transcriptomics Technologies Market
A few driving factors for the demand of transcriptomics technologies market include the growth in the demand for personalized medicine and genetic testing for diseases and variation.
The global prevalence of diseases such as diabetes, hepatitis B and oncological disorders reinforces the importance of drug discovery and development and is a prime motivating factor for significant growth in the transcriptomics technologies market.
Apart from these factors, the rise in the incidence of genetic mutations transpiring in the global population due to the presence of carcinogens is considered as another major driving factor for the growth of the transcriptomics technologies market.
Know More Details About the Report
Technological advancements and their impact in the Transcriptomics Technologies market
Through technological advancements and upgradations, there is an increased rise in automation and these features are applicable in the transcriptome analysis methods like SAGE and amplification of nucleic acids. The use of these mentioned technologies in the analysis of gene expression will further augment the growth and uptake of RNA interference technologies and sequencing.
A key factor in the technology segment owing to the increase in demand for whole RNA sequencing and targeted resequencing is Next-generation sequencing.
U.S. and Canada Transcriptomics Technologies Market Outlook
The U.S. dominates the transcriptomics technologies market in the region of North America. The factors contributing to the significant market share of the country U.S. are associated with revenue through increasing R&D activities in the pharmaceutical and biotechnology industry.
Subsequently, North America is set to witness the fastest growth over the forecast period of 2021-2031 owing to the presence of previously overlooked market opportunities and growing acceptance of expenditure and conductive government initiatives.
The government of Canada has subjected significant funding in terms of transcriptomics technologies through several bodies which include not-for-profit organizations such as Genome Canada and has hence emerged as a subjective regional presence in the market for North America.
Avail customized purchase options for your needs
Europe Demand Outlook for Transcriptomics Technologies
The European transcriptomics technologies market is expected to grow at a profitable rate over the forecast period. This growth is owed to the presence of an increasing number of key players and the opportunistic approach to new investments in the field of transcriptomics technologies.
Furthermore, rising investments in the R&D sector in this region are set to generate momentum for new-age innovation in the transcriptomics technologies market and wound account for global growth in market size for the same.
Who are the Key Manufacturers and Suppliers of Transcriptomics Technologies?
Some of the key players in the Transcriptomics Technologies market include
- Danaher Corp
- Affymetrix Inc
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- Qiagen N.V.
- Thermo Fisher Scientific
- LC Sciences
- Illumina, Inc.
- F-Hoffmann La Roche Ltd.
- Life Technologies Corporation
- GenXPro GmbH
- CD Genomics
- Merck KGaA
- Sequentia Biotech SL.
The major players in the transcriptomics technologies market are focusing on various organic strategies for growth such as new product launches and novel patented technologies. Apart from these, the strategy of acquisitions and collaborations within the key players in addition to technological advancements acting as a prime factor in maintaining their market presence.
An Adaptive Approach to Modern-day Research Needs
Transcriptomics Technologies Market Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company
Have a report related query? Speak to us directly
By Product Type
- Reagent Kits
- Gene Regulation Technologies
- Polymerase Chain Reaction
- Next-Generation Sequencing
- Comparative transcriptomics studies
- Drug discovery and research
- Academic Research and Government Institutes
- Hospitals and Diagnostic Centers
- Pharmaceutical and Biotechnology companies
- North America
- Latin America
- South Asia
- Rest of Asia Pacific
- East Asia
- South Korea
- Middle East and Africa
- GCC Countries
- South Africa
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Need an Exclusive Report for your Unique Requirement?
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report on the radiation proctitis treatment industry has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.